Order Article Reprints

Glynn SE, Lanier CM, Choi AR, D’Agostino R Jr., Farris M, Abdulhaleem M, Wang Y, Smith M, Ruiz J, Lycan T, et al. Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases? Cancers. 2025; 17(6):991. https://doi.org/10.3390/cancers17060991

Glynn, Sarah E., Claire M. Lanier, Ariel R. Choi, Ralph D’Agostino, Jr., Michael Farris, Mohammed Abdulhaleem, Yuezhu Wang, Margaret Smith, Jimmy Ruiz, Thomas Lycan, and et al. 2025. "Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?" Cancers 17, no. 6: 991. https://doi.org/10.3390/cancers17060991

Glynn, S. E., Lanier, C. M., Choi, A. R., D’Agostino, R., Jr., Farris, M., Abdulhaleem, M., Wang, Y., Smith, M., Ruiz, J., Lycan, T., Petty, W. J., Cramer, C. K., Tatter, S. B., Laxton, A. W., White, J. J., Su, J., Whitlow, C. T., Soto-Pantoja, D. R., Xing, F., ... Helis, C. A. (2025). Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases? Cancers, 17(6), 991. https://doi.org/10.3390/cancers17060991